Parvovirus B19, a member of the Parvoviridae family, is a pathogenic virus responsible for a range of clinical conditions such as erythema infectiosum, aplastic anemia, and hydrops fetalis. Accurate serological detection of Parvovirus B19-specific antibodies is essential for diagnosing acute and past infections as well as for epidemiological studies. The Parvovirus ELISA kit, based on enzyme-linked immunosorbent assay (ELISA) technology, provides a reliable method for detecting IgM and IgG antibodies against Parvovirus B19 in human serum and plasma samples.
Features and Performance
- High Specificity and Sensitivity: The use of recombinant viral antigens ensures high immunoglobulin class-specific detection, minimizing cross-reactivity with other pathogens.
- Quantitative and Qualitative Results: Capable of providing qualitative presence/absence results and quantitative titers for monitoring infection stages.
- Versatile Sample Compatibility: Suitable for human serum and plasma, with validated protocols for manual and automated ELISA systems.
- Diagnostic and Epidemiological Utility: Supports early diagnosis of primary infection through IgM detection and assessment of past exposure via IgG detection.
Applications
- Early diagnosis of acute parvovirus infections, especially in pregnant women at risk of fetal hydrops.
- Confirming past exposure in epidemiological surveys.
- Monitoring immune response after vaccination or natural infection.
- Investigating outbreaks of erythema infectiosum or other clinical conditions associated with Parvovirus B19.
The Parvovirus B19 ELISA kit is a crucial serological tool that offers accurate, reliable detection of virus-specific IgM and IgG antibodies. Its high specificity, compatibility with routine diagnostic workflows, and ability to distinguish between recent and past infections make it indispensable in clinical virology, public health, and research settings. The immunoassay’s performance in detecting Parvovirus B19 antibodies enhances diagnostic precision, supports timely clinical decision-making, and contributes to epidemiological understanding of B19 infections.
